Lexipafant

Lexipafant
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T27821-25mg 25 mg -

7 - 10 business days*

1,638.00€
TGM-T27821-50mg 50 mg -

7 - 10 business days*

2,139.00€
TGM-T27821-100mg 100 mg -

7 - 10 business days*

2,748.00€
 
Description: Lexipafant is a platelet-activating factor (PAF) receptor antagonist which inhibits... more
Product information "Lexipafant"
Description: Lexipafant is a platelet-activating factor (PAF) receptor antagonist which inhibits the binding of PAF to its receptor, thereby reducing inflammation and associated tissue injury. [Reduce organ damage, mitigate sepsis]. Target: Others. Smiles: C(N1C=2C(N=C1C)=CN=CC2)C3=CC=C(S(N([C@H](C(OCC)=O)CC(C)C)C)(=O)=O)C=C3. References: Oztürk H, Oztürk H, Dokucu AI, Otcu S. Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats. Acta Gastroenterol Belg. 2006 Apr-Jun,69(2):197-202. PubMed PMID: 16929615.
Keywords: DO6, BB882, BB-882, GR-167089, DO-6, ISV-611
Supplier: TargetMol
Supplier-Nr: T27821

Properties

Application: Targets platelet-activating factor receptor (PTAFR)
MW: 458.57 D
Formula: C23H30N4O4S

Database Information

CAS : 139133-26-9| Matching products
KEGG ID : K04279 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Lexipafant"
Write a review
or to review a product.
Viewed